In Committee from the Senate of Canada - Legal and Constitutional Affairs - May 14, 2015
Senators continue their review of Bill C-2, which would establish criteria that must be met in applications for supervised injection sites. The proposed legislation was introduced in response to the Supreme Court of Canada's 2011 decision that allowed Insite, North America's first and only legally sanctioned supervised injection site, to remain open.
The following witnesses testify: Dr. Jeff Blackmer (vice-president of medical professionalism, Canadian Medical Association); Tom Stamatakis (president of the Canadian Police Association); Marilou Gagnon (an expert advisor for the Canadian Association of Nurses in HIV/AIDS Care); Rebecca Jesseman (director of the Canadian Centre on Substance Abuse); Jean Nelson (director of legal services for the CMA); Donna May (who speaks about her late daughter's struggle with addiction); Dean Wilson (former Insite user and a plaintiff in the Supreme Court case); and Greg Thompson (president of the Urban League of London). (May 14, 2015) UPDATE: Bill C-2 received royal assent on June 18.